Responders | Baseline | 6 ± 1 months | 35 ± 6 months | Mean diff. ± SD*** | Pvalue*** |
---|---|---|---|---|---|
LV EDVI (ml/m 2 ) | 84 ±34 | 84 ±23 | 85 ±24 | 1.6 ±30 | 0.94 |
LV ESVI (ml/m 2 ) | 55 ±24 | 43 ±19* | 41 ±18 | 14 ±15 | <0.001 |
LV SV (ml) | 67 ±24 | 83 ±20* | 92 ±27 | 24 ±24 | <0.001 |
LVEF (%) | 36 ±8 | 51 ±11* | 54 ±11** | 17 ±8 | <0.001 |
MV RF (%) | 22 ±11 | 19 ±12 | 16 ±10 | 5.0 ±10 | 0.021 |
WMSI | 1.8 ±0.4 | 1.4 ±0.4* | 1.4 ±0.5 | 0.4 ±0.4 | <0.001 |
Non-responders | Â | Â | Â | Â | Â |
LV EDVI (ml/m 2 ) | 116 ±29 | 109 ±24 | 124 ±31 | 8.1 ±28 | 0.445 |
LV ESVI (ml/m 2 ) | 77 ±24 | 70 ±19 | 82 ±26 | 4.6 ±21 | 0.575 |
LV SV (ml) | 77 ±22 | 77 ±18 | 84 ±16 | 7 ±19 | 0.359 |
LVEF (%) | 33 ±6 | 36 ±8* | 35 ±5 | 1.3 ±3.8 | 0.113 |
MV RF (%) | 21 ±14 | 19 ±7 | 21 ±13 | 0.4 ±18 | 0.859 |
WMSI | 2.1 ±0.4 | 1.9 ±0.3* | 2.1 ±0.3 | 0.03 ±0.3 | 0.779 |